Clinical Trial

Aspirin and Preeclampsia

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a single-center, double-blind, randomized, placebo-controlled clinical trial. Peripartum and postpartum Activin A are significantly elevated in women with preeclampsia. Our hypothesis is that elevated Activin A levels reflect a remediable signal and that reducing postpartum Activin A levels with aspirin therapy will improve (GLS) in preeclamptic patients.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2020-07-18; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Recruiting 2021-03-09
Trial Details
NCT Number NCT04479072
Lead Sponsor University of Chicago
Conditions Preeclampsia Postpartum
Enrollment 180 participants
Start Date 2021-02-15
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-04